Benralizumab in Chronic Prurigo - Investigating Clinical Efficacy (BICPIC)

NCT05528913 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Financing has been withdrawn

Conditions

Chronic Prurigo

Interventions

DRUG: Fasenra Prefilled Syringe
OTHER: Matching Placebo Solution

Sponsor

Charite University, Berlin, Germany